Elequin Capital »

Mirum Pharmaceuticals shares owned by Elequin Capital

Quarter-by-quarter ownership of Mirum Pharmaceuticals (MIRM) shares owned by Elequin Capital from 13F filings

Historical chart of Elequin Capital investment in Mirum Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Mirum Pharmaceuticals held by Elequin Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Mirum Pharmaceuticals by Elequin Capital

Quarter filed Position value Share count Share price at filing
2023-12-31 $2.7k 93 29.52
2023-09-30 $3.4k 106 31.60

More positions owned by Elequin Capital

Palo Alto Networks Note 0.375% 6/0 (Principal)
Aes Corp Unit 02/15/2024
Pioneer Nat Res Note 0.250% 5/1 (Principal)
United States Stl Corp Note 5.000%11/0 (Principal)
Clarivate 5.25% Pfd Conv A (CLVT.PA)
Algonquin Pwr Utils Corp Unit 06/15/2024 (AQNU)
Ugi Corp Unit 06/01/2024 (UGIC)
Spdr Ser Tr Bbg Conv Sec Etf (CWB)
Conmed Corp Note 2.625% 2/0 (Principal)
Altria (MO)
Mid-America Apartment (MAA)
Proshares Tr Bitcoin Strate (BITO)
Camden Ppty Tr Sh Ben Int (CPT)
Apartment Income Reit Corp (AIRC)
Broadcom (AVGO)

View all positions for Elequin Capital

Top funds holding Mirum Pharmaceuticals

Frazier Life Sciences Management
BVF
Eventide Asset Management
Vanguard Group
Henderson Group
Cadian Capital Management
Citadel Advisors
T. Rowe Price Associates
Avidity Partners Management
Tang Capital Management
Franklin Resources
First Turn Management
William Blair Investment Management
Perceptive Advisors
Boone Capital Management

View all funds holding Mirum Pharmaceuticals